The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions
<p><strong>Background:</strong> Many available medicines have been evaluated as potential repurposed treatments for coronavirus disease 2019 (COVID-19). We summarise the registered study landscape for 32 priority pharmacological treatments identified following consultation with ext...
Main Authors: | McLean, ARD, Rashan, S, Tran, L, Arena, L, Lawal, A, Maguire, BJ, Adele, S, Antonio, ES, Brack, M, Caldwell, F, Carrara, VI, Charles, R, Citarella, BW, Epie, TB, Feteh, VF, Kennon, K, Makuka, GJ, Ngu, R, Nwosu, A-P, Obiesie, S, Ogbonnaa-Njoku, C, Paul, P, Richmond, C, Singh-Phulgenda, S, Strudwick, S, Tyrrell, CSB, Stepniewska, K, Strub-Wourgaft, N, White, NJ, Guérin, PJ |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000Research
2022
|
Similar Items
-
Baseline results of a living systematic review for COVID-19 clinical trial registrations
by: Maguire, BJ, et al.
Published: (2020) -
Baseline results of a living systematic review for COVID-19 clinical trial registrations [version 1; peer review: 2 approved]
by: Brittany J. Maguire, et al.
Published: (2020-06-01) -
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
by: Guerin, PJ, et al.
Published: (2020) -
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? [version 1; peer review: 3 approved, 1 approved with reservations]
by: Philippe J Guerin, et al.
Published: (2020-04-01) -
Definitions matter: heterogeneity of COVID-19 disease severity criteria and incomplete reporting compromise meta-analysis
by: Guérin, PJ, et al.
Published: (2022)